Offer - Urjas Oil for just ₹ 1 X
Nebifid 5 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of High BP.
Medical history of the patient along with age and gender determines the dosage of Nebifid 5 Mg Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Nebifid 5 Mg Tablet can also lead to other problems, which have been listed below. Such side effects of Nebifid 5 Mg Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Nebifid 5 Mg Tablet is Severe for pregnant women and Severe for women who are breastfeeding. Warnings related to Nebifid 5 Mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Nebifid 5 Mg Tablet is contraindicated in people with pre-existing medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) as it can result in adverse effects. Other conditions have been mentioned below in the Nebifid 5 Mg Tablet contraindications section.
Besides this, Nebifid 5 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Nebifid 5 Mg Tablet is considered not safe while driving, and is not addictive.
Nebifid 5 Mg Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Nebifid 5 Mg Tablet safe for pregnant women?
Nebifid shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Nebifid 5 Mg Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Nebifid. So it is adviced to consult the doctor before using it.
What is the effect of Nebifid 5 Mg Tablet on the Kidneys?
Nebifid has very mild side effects on the kidneys.
What is the effect of Nebifid 5 Mg Tablet on the Liver?
Side effects of Nebifid rarely affect the liver.
What is the effect of Nebifid 5 Mg Tablet on the Heart?
Very few cases of side effects of Nebifid on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Nebifid 5 Mg Tablet unless your doctor advises you to do so -
Is this Nebifid 5 Mg Tablet habit forming or addictive?
Nebifid 5 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Nebifid 5 Mg Tablet as you may feel sleepy.
Is it safe?
Yes, but take Nebifid 5 Mg Tablet only as per medical advice.
Is it able to treat mental disorders?
No, the use of Nebifid 5 Mg Tablet in mental disorders is not effective.
Interaction between Food and Nebifid 5 Mg Tablet
Eating certain foods may increase the time it takes Nebifid 5 Mg Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Nebifid 5 Mg Tablet
Taking alcohol with Nebifid 5 Mg Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897